Life AI Net
Inicio
Archivo
Calculadoras
Directorio
Boletín
Hot
Iniciar sesión
Español
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Inicio
Archivo
Calculadoras
Directorio
Boletín
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Iniciar sesión
Inicio
Archivo
Calculadoras
Directorio
More
En vivo
MOONS'
How Artemis will help the U.S. create a moon base - NBC News
Agilent
Agilent Technologies Inc (A) Shares Fall 5.0% -- What GF Score o - GuruFocus
FierceBiotech
Despite data concerns, Roche’s oral SERD can still be largest product in company history: exec
FierceBiotech
Regeneron ushers in new genetic medicine era with groundbreaking gene therapy approval
Thermo Fisher
Thermo Fisher CEO says onshoring push will bring a ‘tailwind’ for the Waltham company - The Business Journals
Agilent
Earnings snapshot: Agilent Technologies misses FQ1 estimates; gives FQ2 and raises FY26 outlook, above forecast - MSN
Thermo Fisher
Thermo Fisher Scientific Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
10x Genomics Blog
Why 10x Genomics (TXG) Shares Are Trading Lower Today - TradingView
FierceBiotech
Kurma closes €215M Europe-focused fund to spread across 20 biotechs
FierceBiotech
Pfizer cans work on next-gen conjugate in cancer patients
BioWorld
Financings for April 23, 2026
BioWorld
In the clinic for April 23, 2026
MOONS'
How Artemis will help the U.S. create a moon base - NBC News
Agilent
Agilent Technologies Inc (A) Shares Fall 5.0% -- What GF Score o - GuruFocus
FierceBiotech
Despite data concerns, Roche’s oral SERD can still be largest product in company history: exec
FierceBiotech
Regeneron ushers in new genetic medicine era with groundbreaking gene therapy approval
Thermo Fisher
Thermo Fisher CEO says onshoring push will bring a ‘tailwind’ for the Waltham company - The Business Journals
Agilent
Earnings snapshot: Agilent Technologies misses FQ1 estimates; gives FQ2 and raises FY26 outlook, above forecast - MSN
Thermo Fisher
Thermo Fisher Scientific Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
10x Genomics Blog
Why 10x Genomics (TXG) Shares Are Trading Lower Today - TradingView
FierceBiotech
Kurma closes €215M Europe-focused fund to spread across 20 biotechs
FierceBiotech
Pfizer cans work on next-gen conjugate in cancer patients
BioWorld
Financings for April 23, 2026
BioWorld
In the clinic for April 23, 2026
Archivo
Buscar
Buscar
Reciente
Más antiguo
Borrar
@BioWorld
Total
1081
Fuente
BioWorld
Búsqueda
--
BioWorld
6 ene 2026
Drugs to Watch 2026: 11 therapies that could transform patient care
BioWorld
6 ene 2026
New year sees Abbvie, Zelgen in $1.1B T-cell engager deal
BioWorld
6 ene 2026
AI drug discovery brings $2B+ Sanofi deal to 1-year-old Earendil
BioWorld
6 ene 2026
Insilico inks $888M drug discovery partnership with Servier
BioWorld
6 ene 2026
Scinopharm wins US FDA approval of multiple sclerosis drug
BioWorld
6 ene 2026
Financings for Jan. 6, 2026
BioWorld
6 ene 2026
Appointments and advancements for Jan. 6, 2026
BioWorld
6 ene 2026
Other news to note for Jan. 6, 2026
BioWorld
6 ene 2026
Regulatory actions for Jan. 6, 2026
BioWorld
5 ene 2026
Med-tech gainers and losers for Dec. 29, 2025-Jan. 2, 2026
BioWorld
5 ene 2026
US vaccine schedule slashed to international standards
BioWorld
5 ene 2026
Appointments and advancements for Jan. 5, 2026
BioWorld
5 ene 2026
Financings for Jan. 5, 2026
BioWorld
5 ene 2026
Other news to note for Jan. 5, 2026
BioWorld
5 ene 2026
Regulatory actions for Jan. 5, 2026
BioWorld
5 ene 2026
Biggest gainers and losers for Dec. 29, 2025-Jan. 2, 2026
BioWorld
5 ene 2026
Psithera spun out of Roivant with $47.5M and immune, inflammatory focus
BioWorld
5 ene 2026
New Nav1.8 blockers disclosed in Jumpcan Pharmaceutical patent
Anterior
44 / 61
Siguiente